Shopping Cart
- Remove All
- Your shopping cart is currently empty
CRTh2 antagonist 3 is a powerful chemokine receptor homologous molecule expressed on Th2 cell (CRTh2) antagonists. CRTh2 antagonist 3 enhanced the activity of PDK1 on short peptide substrates with EC50 of 2 μM and Kd of 8.4 μM. CRTh2 antagonist 3 has the potential to cause cardiovascular inflammation.
Description | CRTh2 antagonist 3 is a powerful chemokine receptor homologous molecule expressed on Th2 cell (CRTh2) antagonists. CRTh2 antagonist 3 enhanced the activity of PDK1 on short peptide substrates with EC50 of 2 μM and Kd of 8.4 μM. CRTh2 antagonist 3 has the |
Targets&IC50 | PDK1:2 μM (EC50), PDK1:8.4 μM (Ki) |
In vitro | CRTh2 antagonist 3 is a small molecule allosteric modulator of structure-based docking protein kinase PDK1. CRTh2 antagonist 3 is 5 times more potent than its parent compound. |
Molecular Weight | 356.44 |
Formula | C19H20N2O3S |
Cas No. | 312928-72-6 |
Relative Density. | 1.26 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.